IPEC e-newsletter - Excipients Insight November/December 2013 - 20-12-13

 

Inside this issue

     

IQ Consortium publishes survey results on drug product life cycle

A survey was conducted through the IQ Consortium members and IPEC members to understand the current practices between pharmaceutical companies and excipient suppliers during the development and throughout the lifecycle of a drug product, according to IPEC-Americas.

Through the understanding of the current practices and identification of challenges, improvement opportunities could be identified. The ultimate goal is to improve safety and efficacy of medical products for patient benefit.

Among the key findings from the survey is that pharmaceutical companies and excipient suppliers work together in some situations however there may be opportunities to better leverage each other’s technical knowledge and abilities to the fullest extent.

In addition, the impact of excipients on drug product properties is being seen at commercial scale that may have been predicted during development. Additional research is recommended to further explore opportunities.

 

 

 

Copyright © 2005 - 2018 IPEC Europe - International Pharmaceutical Excipients Council